Multiple immunoglobulins (antibody cocktail) capable of binding to specific antigenic determinants and intended to be used for the qualitative and/or quantitative detection of multiple protein markers associated with bladder tissue and/or bladder cancer [e.g., p53, CD44, cytokeratin 20 (CK20)] in a clinical specimen.